NCT01338831 2020-12-17
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
Novartis
Phase 1 Completed
Clinical Trials
4 trialsNCT03156127 2017-08-10
A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
Boryung Pharmaceutical Co., Ltd
Phase 1 Withdrawn
NCT00444704 2009-07-10
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed
NCT00427544 2007-12-05
Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed